We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.05%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$5.4B
AUM Growth
+$238M
(+4.6%)
Cap. Flow
+$43.6M
Cap. Flow
% of AUM
0.81%
Top 10 Holdings %
Top 10 Hldgs %
27.43%
Holding
200
New
18
Increased
64
Reduced
88
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$29.9M |
| 2 |
WIFI
Boingo Wireless, Inc.
WIFI
|
+$29.4M |
| 3 |
Columbia Sportswear
COLM
|
+$27.3M |
| 4 |
Eli Lilly
LLY
|
+$23.2M |
| 5 |
Alibaba
BABA
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$29.7M |
| 2 |
Apple
AAPL
|
+$28.4M |
| 3 |
NetEase
NTES
|
+$21.5M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$20.2M |
| 5 |
Las Vegas Sands
LVS
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.96% |
| 2 | Healthcare | 19.22% |
| 3 | Technology | 14.17% |
| 4 | Financials | 13.61% |
| 5 | Industrials | 13.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Ormat Technologies
ORA
$6.97B
| $14.9M | 0.28% |
235,021
-21,973
| -9% | -$1.31M |
|
102
Maximus
MMS
$2.85B
| $14.5M | 0.27% |
200,000
+20,000
| +11% | +$1.45M |
|
103
Trupanion
TRUP
$1.33B
| $14.5M | 0.27% |
400,000
-70,000
| -15% | -$2.3M |
|
|
EVBG
104
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $14.3M | 0.26% |
160,000
-10,000
| -6% | -$790K |
|
|
WAAS
105
DELISTED
AquaVenture Holdings Limited
WAAS
| $14M | 0.26% |
700,000
+200,000
| +40% | +$3.81M |
|
106
First Horizon
FHN
$12.3B
| $13.4M | 0.25% |
900,000
-100,000
| -10% | -$1.45M |
|
107
Alarm.com
ALRM
$2.72B
| $13.4M | 0.25% |
250,000
+100,000
| +67% | +$6.17M |
|
108
Sensient Technologies
SXT
$5.56B
| $13.2M | 0.24% |
180,000
-20,000
| -10% | -$1.41M |
|
|
TVTY
109
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $13.2M | 0.24% |
800,000
-50,000
| -6% | -$965K |
|
110
Keysight
KEYS
$60.5B
| $13.1M | 0.24% |
+146,400
| New | +$12.4M |
|
111
Credicorp
BAP
$29.6B
| $13M | 0.24% |
56,665
| – | – |
|
|
ALXN
112
DELISTED
Alexion Pharmaceuticals
ALXN
| $12.6M | 0.23% |
96,496
+20,000
| +26% | +$2.58M |
|
113
Rollins
ROL
$17.6B
| $12.6M | 0.23% |
525,000
| – | – |
|
114
Synchrony
SYF
$25.8B
| $12.4M | 0.23% |
358,000
-45,000
| -11% | -$1.53M |
|
115
Intercontinental Exchange
ICE
$85B
| $12.3M | 0.23% |
143,500
| – | – |
|
116
Travere Therapeutics
TVTX
$5.85B
| $12.3M | 0.23% |
612,856
+150,000
| +32% | +$2.96M |
|
117
PTC Therapeutics
PTCT
$6.06B
| $12.2M | 0.22% |
+270,000
| New | +$10.7M |
|
|
PFPT
118
DELISTED
Proofpoint, Inc.
PFPT
| $12M | 0.22% |
100,000
| – | – |
|
119
National Bank Holdings
NBHC
$1.92B
| $12M | 0.22% |
330,000
+66,600
| +25% | +$2.41M |
|
|
ARQL
120
DELISTED
Arqule Inc
ARQL
| $11.8M | 0.22% |
1,070,000
-30,000
| -3% | -$209K |
|
|
NBIS
121
Nebius Group N.V.
NBIS
$65.7B
| $11.5M | 0.21% |
303,356
-203,050
| -40% | -$7.54M |
|
|
AERI
122
DELISTED
Aerie Pharmaceuticals
AERI
| $11.4M | 0.21% |
385,800
-10,000
| -3% | -$385K |
|
123
Veeva Systems
VEEV
$39.2B
| $11.2M | 0.21% |
69,374
+13,120
| +23% | +$1.91M |
|
124
Align Technology
ALGN
$12.4B
| $10.9M | 0.2% |
39,649
+8,769
| +28% | +$2.65M |
|
125
Willdan Group
WLDN
$1.3B
| $10.8M | 0.2% |
291,176
+56,058
| +24% | +$2.03M |
|
Similar funds
VIA
Handelsbanken Fonder's Q2 2019 Portfolio in Review
As of Q2 2019, Handelsbanken Fonder held 200 positions worth $5.4B, up 4.6% from $5.17B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Handelsbanken Fonder's Q2 2019 filing shows 18 new, 64 increased, 88 reduced and 11 closed positions. Its largest new stake was JD.com: 650,000 shares worth $19.7M. The largest sale was Johnson & Johnson, an estimated $29.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
- Handelsbanken Fonder's largest Q2 2019 buy was JD.com: 650,000 shares worth $19.7M.
- Handelsbanken Fonder added most to AbbVie in Q2 2019, an estimated $29.9M increase.
- Handelsbanken Fonder's biggest Q2 2019 reduction was Johnson & Johnson, cutting an estimated $29.7M.
- Handelsbanken Fonder fully exited Las Vegas Sands in Q2 2019, selling an estimated $19.1M.
- Handelsbanken Fonder's ten largest holdings make up 27% of its $5.4B portfolio in Q2 2019.
- Handelsbanken Fonder opened 18 new positions and closed 11 in Q2 2019.
- Handelsbanken Fonder's portfolio value rose 4.6% quarter-over-quarter to $5.4B.
Based on Handelsbanken Fonder's 13F filing for Q2 2019, filed 12 Jul 2019.